Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 4, Pages 273–280
http://dx.doi.org/10.1155/2013/612035
Research Article

Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein

1Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
2Iran National Tumor Bank, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
3Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
4Department of Clinical Biochemistry, Faculty of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran
5Epidemiology and Biostatistics Department, Health School, Isfahan University of Medical Sciences, Isfahan, Iran
6Apply Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
7Department of Physics, Safadasht Branch, Islamic Azad University, Tehran, Iran

Received 17 June 2013; Revised 12 August 2013; Accepted 25 August 2013

Academic Editor: Natacha Turck

Copyright © 2013 Maryam Boshtam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. I. Draganov and B. N. La Du, “Pharmacogenetics of paraoxonases: a brief review,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 369, no. 1, pp. 78–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Tward, Y. R. Xia, X. P. Wang et al., “Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice,” Circulation, vol. 106, no. 4, pp. 484–490, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. L. G. Costa, T. B. Cole, G. P. Jarvik, and C. E. Furlong, “Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism,” Annual Review of Medicine, vol. 54, pp. 371–392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Barter, S. Nicholls, K. Rye, G. M. Anantharamaiah, M. Navab, and A. M. Fogelman, “Antiinflammatory properties of HDL,” Circulation Research, vol. 95, no. 8, pp. 764–772, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Fridman, A. G. Fuchs, R. Porcile, A. V. Morales, and L. O. Gariglio, “Paraoxonase: its multiple functions and pharmacological regulation,” Archivos de Cardiologia de Mexico, vol. 81, no. 3, pp. 251–260, 2011. View at Google Scholar · View at Scopus
  6. J. Valabhji, A. J. McColl, M. Schachter, S. Dhanjil, W. Richmond, and R. S. Elkeles, “High-density lipoprotein composition and paraoxonase activity in type 1 diabetes,” Clinical Science, vol. 101, no. 6, pp. 659–670, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Ferretti, T. Bacchetti, S. Masciangelo, and V. Bicchiega, “HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects,” Obesity, vol. 18, no. 6, pp. 1079–1084, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Saeed, M. Elsharkawy, K. Elsaeed, and O. Fooda, “Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients,” Hemodialysis International, vol. 12, no. 4, pp. 471–479, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. L. G. Costa, A. Vitalone, T. B. Cole, and C. E. Furlong, “Modulation of paraoxonase (PON1) activity,” Biochemical Pharmacology, vol. 69, no. 4, pp. 541–550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. W. H. F. Sutherland, R. J. Walker, S. A. de Long, A. M. van Rij, V. Phillips, and H. L. Walker, “Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 5, pp. 1340–1347, 1999. View at Google Scholar · View at Scopus
  11. N. Ferrè, J. Camps, J. Fernández-Ballart et al., “Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population,” Clinical Chemistry, vol. 49, no. 9, pp. 1491–1497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Calabresi, B. Villa, M. Canavesi et al., “An ω-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia,” Metabolism, vol. 53, no. 2, pp. 153–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Ferretti and T. Bacchetti, “Effect of dietary lipids on paraoxonase-1 activity and gene expression,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 22, no. 2, pp. 88–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. B. J. Kudchodkar, A. G. Lacko, L. Dory, and T. V. Fungwe, “Dietary fat modulates serum paraoxonase 1 activity in rats,” Journal of Nutrition, vol. 130, no. 10, pp. 2427–2433, 2000. View at Google Scholar · View at Scopus
  15. S. D. Nguyen, N. D. Hung, P. Cheon-Ho, K. M. Ree, and S. Dai-Eun, “Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1),” Biochimica et Biophysica Acta, vol. 1790, no. 3, pp. 155–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. D. Nguyen and D. E. Sok, “Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization,” Biochemical Journal, vol. 375, no. 2, pp. 275–285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. N. M. de Roos, E. G. Schouten, L. M. Scheek, A. van Tol, and M. B. Katan, “Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women,” Metabolism, vol. 51, no. 12, pp. 1534–1537, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. A. E. Razavi, M. Pourfarzam, M. Ani, and G. A. Naderi, “The associations between high-density lipoprotein mean particle size and its fatty acid composition,” Biomarkers in Medicine, vol. 7, no. 2, pp. 235–245, 2013. View at Publisher · View at Google Scholar
  19. P. Risé, S. Eligini, S. Ghezzi, S. Colli, and C. Galli, “Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 76, no. 6, pp. 363–369, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Razavi, M. Ani, M. Pourfarzam, and G. A. Naderi, “Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity,” Journal of Research in Medical Sciences, vol. 17, no. 11, pp. 1020–1026, 2012. View at Google Scholar
  21. J. Bełtowski, G. Wójcicka, and A. Jamroz, “Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia,” Atherosclerosis, vol. 170, no. 1, pp. 21–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. K. Markwell, S. M. Haas, L. L. Bieber, and N. E. Tolbert, “A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples,” Analytical Biochemistry, vol. 87, no. 1, pp. 206–210, 1978. View at Google Scholar · View at Scopus
  23. J. Folch, M. Lees, and G. H. S. Stanley, “A simple method for the isolation and purification of total lipides from animal tissues,” The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497–509, 1957. View at Google Scholar · View at Scopus
  24. W. R. Morrison and L. M. Smith, “Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride—methanols,” Journal of Lipid Research, vol. 5, pp. 600–608, 1964. View at Google Scholar · View at Scopus
  25. S. D. Nguyen and D. E. Sok, “Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization,” Biochemical Journal, vol. 375, no. 2, pp. 275–285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. N. M. de Roos, E. G. Schouten, L. M. Scheek, A. van Tol, and M. B. Katan, “Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women,” Metabolism, vol. 51, no. 12, pp. 1534–1537, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Tomás, M. Sentí, R. Elosua et al., “Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity,” European Journal of Pharmacology, vol. 432, no. 2-3, pp. 121–128, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Wallace, W. H. F. Sutherland, J. I. Mann, and S. M. Williams, “The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes,” European Journal of Clinical Nutrition, vol. 55, no. 11, pp. 951–958, 2001. View at Publisher · View at Google Scholar · View at Scopus